Back pain: Lancet review calls for clinical assessment over routine scans

A new systematic review published in The Lancet has reignited the debate over the role of imaging in the management of low‑back pain, arguing that routine scans are rarely justified and that clinical assessment should remain the cornerstone of diagnosis. The review, which examined data from more than 200 randomized controlled trials and cohort studies spanning three decades, found that in the overwhelming majority of cases – estimated at around 90 % – back pain is non‑specific and resolves without the need for advanced imaging such as magnetic resonance imaging (MRI) or computed tomography (CT). The authors contend that current guidelines, which already prioritise patient education, physical activity and self‑management, need to be reinforced with clearer recommendations to limit imaging to situations where red‑flag symptoms suggest serious underlying disease.The analysis was led by a multinational team of researchers from the United Kingdom, the United States, Canada and Australia, who sought to address what they described as “persistent over‑use of diagnostic imaging in primary care settings”..

Their meta‑analysis identified a consistent pattern: patients who received an early MRI were no more likely to experience pain relief or functional improvement than those who were managed conservatively, yet they incurred substantially higher costs and were more likely to undergo unnecessary surgical referrals. In one of the larger pooled studies, 28 % of patients who were scanned were subsequently offered spinal surgery, compared with just 12 % of those who were not imaged, despite similar clinical presentations.The review underscores the importance of recognising red‑flag signs – such as unexplained weight loss, night pain, recent trauma, immunosuppression, or neurological deficits – as the primary triggers for imaging. In the absence of these indicators, the authors argue that clinicians should rely on a thorough history and physical examination to rule out serious pathology, and then focus on evidence‑based non‑pharmacological interventions..

“The evidence overwhelmingly supports a ‘watchful waiting’ approach coupled with education on activity modification and exercise,” the lead author wrote in the accompanying editorial. “Routine imaging not only fails to improve outcomes but also opens the door to a cascade of interventions that may be unnecessary or even harmful.”The findings echo recommendations from existing national bodies such as the National Institute for Health and Care Excellence (NICE) in England, which advise against imaging in the first six weeks of uncomplicated low‑back pain. However, the authors of the Lancet review point out a gap between guideline publication and real‑world practice..

Survey data from general practitioners in the United Kingdom, the United States and Canada reveal that up to 40 % of clinicians still order an MRI within the first month of presentation, often in response to patient expectations or perceived medico‑legal pressure. The review suggests that addressing these drivers – through clinician education, shared decision‑making tools and public information campaigns – could markedly reduce unnecessary imaging.Critics of the review caution that while the evidence for routine imaging is weak, there remains a subset of patients for whom early diagnosis is crucial. Orthopaedic surgeon Dr Helen Marshall, who was not involved in the study, highlighted that “rare but serious conditions such as spinal infections, malignancy or cauda equina syndrome can present with relatively mild symptoms initially.” She urged that any policy aimed at curbing imaging must safeguard clinicians’ ability to act swiftly when red‑flag features emerge, and that training programmes should emphasise the identification of these warning signs.Health economists cited in the review estimate that the United Kingdom alone spends approximately £150 million annually on back‑pain imaging that yields little clinical benefit..

The authors argue that reallocating these resources toward multidisciplinary rehabilitation programmes – incorporating physiotherapy, occupational therapy and cognitive‑behavioural strategies – could deliver better outcomes at a lower cost. Preliminary data from pilot projects in several NHS trusts indicate that patients offered structured exercise and education programmes report faster pain reduction and lower recurrence rates than those managed with a “scan‑first” approach.Patient advocacy groups have responded with mixed reactions. The Back Pain Support Network welcomed the emphasis on non‑invasive management, noting that many members feel pressured to undergo scans that do not change their treatment plan..

Conversely, the Chronic Pain Alliance warned that “some patients fear that clinicians will dismiss their concerns if imaging is not offered,” urging the medical community to maintain open communication and validate patients’ experiences even when imaging is deemed unnecessary.The review also touches on the psychological impact of imaging findings. Studies referenced in the analysis show that incidental abnormalities – such as disc bulges or degenerative changes that are common in asymptomatic individuals – can lead to increased anxiety, fear‑avoidance behaviours and a heightened perception of pain. By avoiding unnecessary scans, clinicians may help prevent these adverse psychosocial effects, fostering a more positive recovery trajectory.In light of the evidence, the authors call for a coordinated effort to embed the “clinical assessment first” principle into everyday practice..

Recommendations include revising electronic health record prompts that default to imaging orders, integrating decision‑support algorithms that flag red‑flag criteria, and expanding access to community‑based physiotherapy services. They also advocate for research into patient‑centred communication strategies that can effectively convey the limited value of routine scans while preserving trust.The Lancet review arrives at a time when health systems worldwide are grappling with rising costs and the need to optimise resource utilisation. As policymakers, clinicians and patients digest its implications, the central message remains clear: for the vast majority of low‑back pain sufferers, careful clinical evaluation and evidence‑based non‑pharmacological treatment should precede, not follow, the decision to image..

The challenge now lies in translating this evidence into practice, ensuring that patients receive the right care at the right time without the burden of unnecessary investigations..